Dogwood Therapeutics (DWTX)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	2.04 mm	2.04 mm	2.04 mm	2.04 mm	2.04 mm	2.04 mm
Cash burn (monthly)	326.79 k	228.86 k	767.06 k	485.27 k	303.38 k	344.04 k
Cash used (since last report)	1.74 mm	1.22 mm	4.07 mm	2.58 mm	1.61 mm	1.83 mm
Cash remaining	304.76 k	824.71 k	-2.03 mm	-536.68 k	429.05 k	213.17 k
Runway (months of cash)	0.9	3.6	-2.7	-1.1	1.4	0.6

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

DWTX institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	22	25	-12.0%
Opened positions	6	7	-14.3%
Closed positions	9	5	+80.0%
Increased positions	5	3	+66.7%
Reduced positions	2	1	+100.0%

13F shares	Current	Prev Q	Change
Total value	163.18 mm	192.41 mm	-15.2%
Total shares	2.63 mm	2.55 mm	+3.0%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Brian David Corday	882.40 k	$0.00	0.0%
IOI Ionic Ventures	697.29 k	$0.00	0.0%
Geode Capital Management	230.75 k	$39.23 mm	+32.3%
Vanguard	208.88 k	$35.51 mm	0.0%
UBS UBS	186.06 k	$31.63 mm	+22.6%
HRT Financial	81.57 k	$13.00 k	+41.8%
Two Sigma Securities	53.39 k	$9.08 mm	NEW
STT State Street	52.83 k	$8.98 mm	0.0%
Garden State Investment Advisory Services	52.00 k	$8.84 mm	NEW
McCollum Christoferson	33.50 k	$5.70 mm	-41.2%

Largest transactions	Shares	Bought/sold	Change
Susquehanna International	0.00	-65.99 k	EXIT
Geode Capital Management	230.75 k	+56.28 k	+32.3%
Two Sigma Securities	53.39 k	+53.39 k	NEW
Garden State Investment Advisory Services	52.00 k	+52.00 k	NEW
XTX Topco	0.00	-42.65 k	EXIT
UBS UBS	186.06 k	+34.28 k	+22.6%
HRT Financial	81.57 k	+24.03 k	+41.8%
McCollum Christoferson	33.50 k	-23.50 k	-41.2%
RF Regions Financial	0.00	-20.07 k	EXIT
Renaissance Technologies	16.50 k	+16.50 k	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

DWTX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
26 Feb 24	Roger Michael Gendreau	Stock Option Common Stock	Grant	Acquire A	No	No	0.357	88,085	31.45 k	88,085
26 Feb 24	Ralph Grosswald	Stock Option Common Stock	Grant	Acquire A	No	No	0.357	62,568	22.34 k	62,568

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

12 Health Care Stocks Moving In Monday's Pre-Market Session

27 Jan 25

12 Health Care Stocks Moving In Monday's Pre-Market Session

27 Jan 25

Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket

27 Jan 25

12 Health Care Stocks Moving In Friday's Pre-Market Session

24 Jan 25

12 Health Care Stocks Moving In Friday's Pre-Market Session

24 Jan 25

Press releases

From Benzinga Pro

Dogwood Therapeutics Announces Patient Dosing in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy Induced Neuropathy (CINP) to Commence First Quarter of 2025

21 Jan 25

ATLANTA, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (NASDAQ:DWTX) (the "Company"), a development-stage biopharmaceutical company focused on advancing first-in class, non-opioid, Nav 1.7 inhibitor